Latest Trials Latest NewsFAQ

Medical University of South Carolina

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1955-01-01

Employees: 10K

Market Cap: -

Website: https://www.muschealth.com

Clinical Trials

Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper

Not Applicable

Completed

Conditions: Opioid Pain Medication
Chronic Pain

Interventions: Drug: Buprenorphine taper - Phase II
Drug: Buprenorphine Initiation - Phase I
Drug: Gabapentin + Buprenorphine - Phase II
Drug: Placebo + Buprenorphine - Phase II

First Posted Date: 2016-04-14

Last Posted Date: 2022-12-01

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 32

Registration Number: NCT02737826

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

N-acetylcysteine for Tobacco Use Disorder

Phase 2

Completed

Conditions: Nicotine Dependence
Smoking

Interventions: Other: Placebo
Drug: N-acetylcysteine (NAC)

First Posted Date: 2016-04-13

Last Posted Date: 2020-08-17

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 114

Registration Number: NCT02737358

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: cholecalciferol
Other: placebo

First Posted Date: 2016-04-01

Last Posted Date: 2019-12-03

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 50

Registration Number: NCT02726113

Locations: 🇺🇸
Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States
🇺🇸
MUSC (Medical University of South Carolina), Charleston, South Carolina, United States

Marijuana Approach Bias Retraining and Neural Response in Youth

Not Applicable

Completed

Conditions: Alcohol Approach/Avoidance Task
Sham Approach/Avoidance Task

Interventions: Behavioral: Marijuana Approach Avoidance Training

First Posted Date: 2016-03-30

Last Posted Date: 2018-09-28

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 41

Registration Number: NCT02723149

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

The Effects of CBT and tDCS on Fibromyalgia Patients

Not Applicable

Completed

Conditions: Fibromyalgia
Chronic Pain

Interventions: Device: Transcranial Direct Current Stimulation

First Posted Date: 2016-03-30

Last Posted Date: 2018-11-28

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 15

Registration Number: NCT02723175

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Translational Neuropsychopharmacology Research of Nicotine Addiction

Phase 2

Completed

Conditions: Nicotine Dependence, Cigarettes

Interventions: Drug: Varenicline (VRN)
Drug: N-Acetylcysteine (NAC)
Drug: Placebo

First Posted Date: 2016-03-30

Last Posted Date: 2022-08-18

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 67

Registration Number: NCT02723162

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Minocycline Administration During Human Liver Transplantation

Phase 4

Withdrawn

Conditions: Liver Disease

Interventions: Drug: Minocycline (yes/no)
Drug: Placebo

First Posted Date: 2016-03-18

Last Posted Date: 2018-06-18

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT02712775

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.

Not Applicable

Completed

Conditions: Atrial Fibrillation

Interventions: Drug: sevoflurane
Drug: propofol

First Posted Date: 2016-03-03

Last Posted Date: 2024-08-20

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 135

Registration Number: NCT02697448

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

Early Phase 1

Completed

Conditions: RENAL INSUFFICIENCY, CHRONIC
HEART DISEASE
LIVER FAILURE, ACUTE

Interventions: Biological: ProQuad

First Posted Date: 2016-02-22

Last Posted Date: 2019-02-12

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 5

Registration Number: NCT02687763

Locations: 🇺🇸
Medical University of South Carolina, Pediatric Nephrology, Charleston, South Carolina, United States

Neural Substrates of Emotion: Impact of Cocaine Dependence

Phase 2

Completed

Conditions: Cocaine Use Disorder

Interventions: Drug: Placebo
Drug: Oxytocin

First Posted Date: 2016-02-15

Last Posted Date: 2021-10-21

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 138

Registration Number: NCT02682784

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy